The global gene therapy market has been experiencing unprecedented growth, driven by advancements in biotechnology and increasing investments in research and development. According to the latest report from gene therapy market size was valued at USD 7.35 billion in 2022 and is projected to reach USD 30.15 billion by 2030, with a staggering compound annual growth rate (CAGR) of 19.3% during the forecast period of 2023-2030.
Gene therapy, a cutting-edge approach to treating genetic disorders, holds immense promise for revolutionizing healthcare by addressing diseases at their root cause. With significant progress in understanding gene editing techniques such as CRISPR-Cas9 and advancements in viral vectors for delivering therapeutic genes, the field of gene therapy has witnessed accelerated development.
Key players
Some major key players in Gene Therapy Market are REGENXBIO, Inc., Taxus Cardium Pharmaceuticals Group, Inc., Oxford BioMedica plc, Bristol-Myers Squibb Company, Dimension Therapeutics, Inc., Applied Genetic Technologies Corporation, SANOFI, bluebird Bio, Inc., Novartis AG, F. Hoffmann-La Roche Ltd. and other players.
Get Sample PDF @
https://www.snsinsider.com/sample-request/3261
Key factors driving the growth of the gene therapy market include:
Technological Advancements:
Continuous innovation in gene editing technologies and viral vectors has enhanced the efficiency and safety of gene therapy, expanding its applicability across various medical conditions.
Increasing Prevalence of Genetic Disorders:
The rising incidence of genetic diseases, coupled with the limited efficacy of conventional treatments, has created a pressing need for alternative therapeutic approaches like gene therapy.
Expanding Investment and Funding
: Growing investments from both public and private sectors in gene therapy research and development initiatives have fueled the expansion of the market, facilitating the translation of promising scientific discoveries into viable clinical therapies.
Regulatory Support:
KEY MARKET SEGMENTS
By Vector Type
Non-Viral Vector
Viral Vector
By Therapy
Ex Vivo Therapy
In Vivo Therapy
By Gene Type
Antigen
Growth factors
Tumor Suppressor
Cytokine
Suicide
Receptors
Deficiency
Others
By Application
Neurological Disorders
Rare Diseases
Oncological Disorders
Other Diseases
Regulatory agencies around the world are increasingly recognizing the potential of gene therapy and are streamlining approval processes to expedite the development and commercialization of gene-based treatments.
The forecasted exponential growth of the gene therapy market underscores its transformative potential in addressing unmet medical needs and improving patient outcomes. As the industry continues to evolve, collaborations between biopharmaceutical companies, academic institutions, and regulatory bodies will be pivotal in driving innovation and ensuring the successful translation of gene therapy from bench to bedside.
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Akash Anand – Head of Business Development & Strategy
info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Website:
https://www.snsinsider.com
Locked
